APT Medical Hits Day High with 4.21% Surge, Outperforming Market

APT Medical, Inc., a large-cap player in the miscellaneous industry, has shown significant activity today, gaining 4.21% on October 22, 2025. The stock reached an intraday high of CNY 334.93, reflecting its strong performance relative to the broader market.
Over the past week, APT Medical has outperformed the China Shanghai Composite, with a weekly gain of 6.53% compared to the index's 1.32%. The company's performance over the last month stands at an impressive 10.26%, while its year-to-date increase is 29.24%, significantly higher than the composite's 16.84%.

APT Medical's financial metrics indicate robust growth, with net sales for the first nine months reaching CNY 1,732.94 million, marking a 21.99% increase. The company boasts a return on equity of 26.46% and a high dividend yield of 0.40%. With a market capitalization of CNY 42,445 million and a price-to-earnings ratio of 57.00, APT Medical continues to demonstrate consistent returns, outperforming the China Shanghai Composite over the last three years.